Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • RE: Risk of HBV Reactivation i...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy

RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy

Bibliographic Details
Main Authors: İlkay Ergenç, Haluk Tarık Kani, Murat Karabacak, Elif Cömert Özer, Shahin Mehdiyev, Fuad Jafarov, Kerem Yiğit Abacar, Seda Kutluğ Ağaçkıran, Gizem Sevik, Rahmi Aslan, Fatma Alibaz Öner, Nevsun İnanç, Mehmet Pamir Atagündüz, Dilek Seçkin, Yeşim Özen Alahdab, Tülin Ergun, Haner Direskeneli, Özlen Atuğ
Format: Article
Language:English
Published: AVES 2023-03-01
Series:The Turkish Journal of Gastroenterology
Online Access:https://www.turkjgastroenterol.org/en/re-risk-of-hbv-reactivation-in-hbsag-negative-and-antihbc-igg-positive-patients-receiving-biologic-therapy-137034
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.turkjgastroenterol.org/en/re-risk-of-hbv-reactivation-in-hbsag-negative-and-antihbc-igg-positive-patients-receiving-biologic-therapy-137034

Similar Items

  • Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B
    by: İlkay Ergenç, et al.
    Published: (2023-02-01)
  • Risk of HBV liver disease in isolated antiHbc patients receiving immuno-chemotherapy for non Hodgkin lymphoma
    by: C. Targhetta, et al.
    Published: (2008-11-01)
  • Detection of MAFLD in Patients with Isolated AntiHBC Ig G Positive Hepatitis B Who Need Immunosuppressive Therapy
    by: Çiğdem Mermutluoğlu, et al.
    Published: (2023-10-01)
  • Update on the Diagnosis of Behçet’s Disease
    by: Fatma Alibaz-Oner, et al.
    Published: (2022-12-01)
  • Biologic treatments in Behçet’s disease
    by: Fatma Alibaz-Öner, et al.
    Published: (2021-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs